FDA pauses US authorization for Eli Lilly's COVID treatment drug
December 01, 2022 at 12:02 PM EST
The Food and Drug Administration said on Wednesday that the Eli Lilly COVID-19 treatment bebtelovimab is not currently authorized for emergency use in the U.S.
